Physician profile
Rohit Sood
NPI 1427293117
$4,761.59
in general payments reported to CMS, 2019-2025
17 companies · $685 in 2025
The $685 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $586 · 2020: $543 · 2021: $569 · 2022: $559 · 2023: $782 · 2024: $1,037 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,488 · Education: $16.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,488.09 |
| Education | $16.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,504.73 | 2019-2025 | Trulance, Xifaxan, Plenvu |
| Abbvie INC. | $495.72 | 2019-2025 | Rinvoq, Linzess, Skyrizi |
| Takeda Pharmaceuticals U.S.A., INC. | $482.84 | 2019-2025 | Entyvio, Eohilia |
| Janssen Biotech, INC. | $358.66 | 2023-2025 | Stelara, Tremfya, Simponi |
| Ardelyx, INC. | $275.02 | 2022-2025 | Ibsrela |
| Merck Sharp & Dohme LLC | $157.29 | 2019-2023 | Dificid, Zerbaxa |
| Lilly USA, LLC | $110.93 | 2024 | Omvoh |
| Regeneron Healthcare Solutions, INC. | $84.50 | 2024-2025 | Dupixent |
| Phathom Pharmaceuticals, INC. | $68.40 | 2024-2025 | Voquezna |
| Evoke Pharma, INC. | $56.45 | 2022-2023 | Gimoti |
| Intercept Pharmaceuticals, INC. | $44.08 | 2019-2022 | |
| Braintree Laboratories, INC. | $32.60 | 2019-2024 | Suflave |
| Nestle Healthcare Nutrition INC. | $27.47 | 2021 | |
| Aimmune Therapeutics, INC. | $18.85 | 2025 | Zenpep |
| Celltrion USA INC. | $16.35 | 2024 | Zymfentra |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $15.00 | 2022 | |
| Qol Medical, LLC | $12.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Sood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.